Shasun Pharmaceuticals Ltd.[Merged] - Research Center
524552 SHASUNPHAR Group (B) BSE data
Results
Statement
More
Mar ' 15 |
Mar ' 14 |
Mar ' 13 |
Mar ' 12 |
Mar ' 11 |
Equity share capital
12.03 |
11.33 |
11.33 |
11.03 |
9.71 |
Share application money
Preference share capital
Reserves & surplus
382.35 |
303.94 |
273.88 |
248.65 |
161.78 |
Secured loans
520.44 |
488.66 |
314.71 |
183.02 |
172.85 |
Unsecured loans
0.52 |
0.88 |
55.83 |
31.28 |
23.10 |
Total
934.87 |
804.81 |
655.74 |
476.79 |
367.44 |
Gross block
767.65 |
581.19 |
519.18 |
441.48 |
398.76 |
Less : revaluation reserve
Less : accumulated depreciation
341.52 |
304.57 |
251.80 |
247.15 |
232.58 |
Net block
426.13 |
276.62 |
267.39 |
194.33 |
166.17 |
Capital work-in-progress
65.96 |
101.69 |
80.86 |
30.81 |
4.93 |
Investments
62.44 |
57.42 |
50.90 |
5.04 |
2.35 |
Current assets, loans & advances
764.50 |
711.00 |
516.01 |
482.14 |
391.24 |
Less : current liabilities & provisions
384.15 |
341.92 |
259.41 |
235.53 |
197.25 |
Total net current assets
380.35 |
369.08 |
256.60 |
246.61 |
193.99 |
Miscellaneous expenses not written
Total
934.87 |
804.81 |
655.74 |
476.79 |
367.44 |
Book value of unquoted investments
68.83 |
57.42 |
50.90 |
5.04 |
2.35 |
Market value of quoted investments
Contingent liabilities
261.60 |
222.48 |
173.09 |
291.43 |
352.96 |
Number of equity sharesoutstanding (Lacs)
601.24 |
566.24 |
566.24 |
551.24 |
485.45 |